Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 200

1.

Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity.

Cuthbertson DJ, Babraj J, Leese G, Siervo M.

Clin Nutr. 2016 Nov 25. pii: S0261-5614(16)31328-0. doi: 10.1016/j.clnu.2016.11.012. [Epub ahead of print]

PMID:
28017449
2.

Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.

Scanlon PH, Stratton IM, Bachmann MO, Jones C, Leese GP; Four Nations Diabetic Retinopathy Screening Study Group..

Diabet Med. 2016 Dec;33(12):1655-1658. doi: 10.1111/dme.13263.

PMID:
27646856
3.

Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study.

Aucott LS, Philip S, Avenell A, Afolabi E, Sattar N, Wild S; Scottish Diabetes Research Network Epidemiology Group..

BMJ Open. 2016 Jul 26;6(7):e010836. doi: 10.1136/bmjopen-2015-010836.

4.

The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS).

Soto-Pedre E, Newey PJ, Bevan JS, Greig N, Leese GP.

Clin Endocrinol (Oxf). 2017 Jan;86(1):60-67. doi: 10.1111/cen.13156.

PMID:
27434534
5.

CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes.

Dawed AY, Donnelly L, Tavendale R, Carr F, Leese G, Palmer CN, Pearson ER, Zhou K.

Diabetes Care. 2016 Nov;39(11):1902-1908.

PMID:
27271184
6.

Thyroxine replacement: a clinical endocrinologist's viewpoint.

Eligar V, Taylor PN, Okosieme OE, Leese GP, Dayan CM.

Ann Clin Biochem. 2016 Jul;53(Pt 4):421-33. doi: 10.1177/0004563216642255. Review.

PMID:
27126268
7.

Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.

Scotland G, McKeigue P, Philip S, Leese GP, Olson JA, Looker HC, Colhoun HM, Javanbakht M.

Diabet Med. 2016 Jul;33(7):886-95. doi: 10.1111/dme.13129.

PMID:
27040994
8.

An audit of the management of childhood-onset growth hormone deficiency during young adulthood in Scotland.

Ahmid M, Fisher V, Graveling AJ, McGeoch S, McNeil E, Roach J, Bevan JS, Bath L, Donaldson M, Leese G, Mason A, Perry CG, Zammitt NN, Ahmed SF, Shaikh MG.

Int J Pediatr Endocrinol. 2016;2016:6. doi: 10.1186/s13633-016-0024-8.

9.

Liothyronine use in a 17 year observational population-based study - the tears study.

Leese GP, Soto-Pedre E, Donnelly LA.

Clin Endocrinol (Oxf). 2016 Dec;85(6):918-925. doi: 10.1111/cen.13052.

PMID:
26940864
10.

Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study.

Wake DJ, Broughton P, Perera SM, MacIntyre DJ, Leese GP.

Psychoneuroendocrinology. 2016 Apr;66:214-20. doi: 10.1016/j.psyneuen.2016.01.022.

PMID:
26849203
11.

Core Standards of the EUBIROD Project. Defining a European Diabetes Data Dictionary for Clinical Audit and Healthcare Delivery.

Cunningham SG, Carinci F, Brillante M, Leese GP, McAlpine RR, Azzopardi J, Beck P, Bratina N, Bocquet V, Doggen K, Jarosz-Chobot PK, Jecht M, Lindblad U, Moulton T, Metelko Ž, Nagy A, Olympios G, Pruna S, Skeie S, Storms F, Di Iorio CT, Massi Benedetti M.

Methods Inf Med. 2016;55(2):166-76. doi: 10.3414/ME15-01-0016.

PMID:
26666452
12.

Response to Comment on Leese et al. Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals. Diabetes Care 2015;38:488-494.

Leese GP, Stratton IM, Land M, Bachmann MO, Jones C, Scanlon P, Looker HC, Ferguson B; Four Nations Diabetic Retinopathy Screening Study Group..

Diabetes Care. 2015 Dec;38(12):e209-10. doi: 10.2337/dci15-0015. No abstract available.

PMID:
26604286
13.

When and how to audit a diabetic foot service.

Leese GP, Stang D.

Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:311-7. doi: 10.1002/dmrr.2749.

PMID:
26452683
14.

Pre-operative serum alkaline phosphatase as a predictive indicator of post-operative hypocalcaemia in patients undergoing total thyroidectomy.

Miah MS, Mahendran S, Mak C, Leese G, Smith D.

J Laryngol Otol. 2015 Nov;129(11):1128-32. doi: 10.1017/S0022215115002352.

PMID:
26415610
15.
16.

Screening attendance, age group and diabetic retinopathy level at first screen.

Scanlon PH, Stratton IM, Leese GP, Bachmann MO, Land M, Jones C, Ferguson B; Four Nations Diabetic Retinopathy Screening Study Group..

Diabet Med. 2016 Jul;33(7):904-11. doi: 10.1111/dme.12957.

17.

Association between retinal vasculature and muscle mass in older people.

Sumukadas D, McMurdo M, Pieretti I, Ballerini L, Price R, Wilson P, Doney A, Leese G, Trucco E.

Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):425-8. doi: 10.1016/j.archger.2015.08.006.

PMID:
26276247
18.

Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee.

Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, Leese G, McCabe C, Perros P, Smith V, Williams G, Vanderpump M.

Clin Endocrinol (Oxf). 2016 Jun;84(6):799-808. doi: 10.1111/cen.12824. Review.

PMID:
26010808
19.

Asymptomatic and mild primary hyperparathyroidism.

Macfarlane DP, Yu N, Leese GP.

Ann Endocrinol (Paris). 2015 May;76(2):120-7. doi: 10.1016/j.ando.2015.03.001. Review.

PMID:
25882891
20.

The Authors' Reply: Statins and thyroid-stimulating hormone.

Leese G.

Clin Endocrinol (Oxf). 2015 Nov;83(5):747-8. doi: 10.1111/cen.12757. No abstract available.

PMID:
25711238

Supplemental Content

Loading ...
Support Center